S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:CNST

Constellation Pharmaceuticals Insider Trades

Notice: This company has been marked as potentially delisted and may not be actively trading.
$33.99
0.00 (0.00%)
(As of 07/15/2021)
Add
Compare
Today's Range
$33.99
$33.99
50-Day Range
$33.63
$33.99
52-Week Range
$17.00
$39.30
Volume
N/A
Average Volume
940,325 shs
Market Capitalization
$1.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.59

Constellation Pharmaceuticals (NASDAQ:CNST) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
43.70%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
4

Amount Of
Insider Selling
(Last 12 Months)
$1.68 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get CNST Insider Trade Alerts

Want to know when executives and insiders are buying or selling Constellation Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Constellation Pharmaceuticals (NASDAQ CNST) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2021Emma ReeveCFOSell6,260$37.60$235,376.004,010  
2/19/2021Emma ReeveCFOSell4,010$37.71$151,217.104,010  
2/17/2021Group L P ColumnMajor ShareholderSell10,000$36.95$369,500.00  
1/19/2021Karen ValentineInsiderSell17,203$33.97$584,385.9117,203  
12/21/2020Emma ReeveCFOSell5,720$35.11$200,829.201,178  
12/21/2020Mark A GoldsmithDirectorSell4,020$35.02$140,780.40  
6/8/2020Emma ReeveCFOSell589$37.55$22,116.95589  
5/12/2020Adrian SenderowiczInsiderSell9,357$50.18$469,534.2625,241  
5/12/2020James E AudiaDirectorSell6,100$50.10$305,610.0025,434  
5/11/2020Emma ReeveCFOSell16,062$49.53$795,550.866,085  
5/8/2020Emma ReeveCFOSell12,741$49.53$631,061.736,085  
5/6/2020James E AudiaDirectorSell7,500$45.15$338,625.0031,534  
5/6/2020Patrick TrojerInsiderSell10,000$45.16$451,600.007,164  
4/27/2020Mark A GoldsmithDirectorSell400$40.12$16,048.00400  
4/20/2020Karen ValentineInsiderSell789$33.65$26,549.85789  
4/17/2020Emma ReeveCFOSell760$35.29$26,820.40760  
4/16/2020Karen ValentineInsiderSell2,998$33.57$100,642.862,998  
4/14/2020Emma ReeveCFOSell1,225$35.20$43,120.001,225  
4/9/2020Emma ReeveCFOSell700$35.02$24,514.00111  
4/9/2020Karen ValentineInsiderSell635$35.02$22,237.70635  
3/20/2020Group L P ColumnMajor ShareholderBuy41,674$28.95$1,206,462.30  
2/13/2020Emma ReeveCFOSell5,521$35.06$193,566.261,103  
2/13/2020Karen ValentineInsiderSell4,473$35.07$156,868.111,500  
2/11/2020Emma ReeveCFOSell8,642$35.04$302,815.68200  
2/11/2020Karen ValentineInsiderSell8,550$35.03$299,506.5014,096  
12/13/2019Anthony B EvninDirectorBuy400,000$34.50$13,800,000.00  
11/12/2019Of The University Of C RegentsMajor ShareholderSell187,116$38.48$7,200,223.68
11/6/2019Adrian SenderowiczInsiderSell27,232$30.91$841,741.12
11/6/2019Emma ReeveCFOSell65,626$30.91$2,028,499.66
11/6/2019James E AudiaDirectorSell22,500$30.91$695,475.00
10/23/2019James E AudiaDirectorSell5,212$13.56$70,674.72
10/23/2019Patrick TrojerInsiderSell10,285$13.56$139,464.60
10/3/2019Anthony B EvninDirectorBuy2,823,529$8.50$23,999,996.50
10/3/2019Group L P ColumnMajor ShareholderBuy1,411,764$8.50$11,999,994.00
7/23/2018Alexandria Venture InvestmentsMajor ShareholderBuy66,667$15.00$1,000,005.00  
7/23/2018Anthony B EvninDirectorBuy133,334$15.00$2,000,010.00  
7/23/2018James E FlynnInsiderBuy200,000$15.00$3,000,000.00  
(Data available from 1/1/2013 forward)












Constellation Pharmaceuticals (NASDAQ:CNST) Insider Trade Frequently Asked Questions

Who is on Constellation Pharmaceuticals's Insider Roster?

The list of insiders at Constellation Pharmaceuticals includes Adrian Senderowicz, Anthony B Evnin, Emma Reeve, Group L P Column, James E Audia, Karen Valentine, Mark A Goldsmith, Of The University Of C Regents, and Patrick Trojer.Learn more on CNST's insiders

What percentage of Constellation Pharmaceuticals stock is owned by insiders?

43.70% of Constellation Pharmaceuticals stock is owned by insiders. Learn more on CNST's insider holdings

Which Constellation Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased Constellation Pharmaceuticals stock in the last 24 months: Anthony B Evnin ($13,800,000.00), and Group L P Column ($1,206,462.30).

How much insider buying is happening at Constellation Pharmaceuticals?

Insiders have purchased a total of 441,674 Constellation Pharmaceuticals shares in the last 24 months for a total of $15,006,462.30 bought.

Which Constellation Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Constellation Pharmaceuticals stock in the last 24 months: Adrian Senderowicz ($469,534.26), Emma Reeve ($2,626,988.18), Group L P Column ($369,500.00), James E Audia ($644,235.00), Karen Valentine ($1,190,190.93), Mark A Goldsmith ($156,828.40), and Patrick Trojer ($451,600.00).

How much insider selling is happening at Constellation Pharmaceuticals?

Insiders have sold a total of 144,255 Constellation Pharmaceuticals shares in the last 24 months for a total of $5,908,876.77 sold.

This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.